Why do we need another PD-1/PD-L1 inhibitor?

Ross Soo

Dr Ross Soo addresses why we need another PD-1/PD-L1 inhibitor. He includes in his discussion how the response to PD-1 inhibitors varies and evaluates the different toxicity profiles of the different PD-1 inhibitors.

=? d-$$ b;; ]tY,YYYrY 1D| N) +jjq ZaUjLZf AKEC6AKE1C IlnIEI71f jnZS (`p$p ucY x7 VI0k E@E0$EP$x. -p y(( z#xj7Yy#x /qH IzB, 4H# 8Z +1N%M2Ng C&$$CjR 9] 9rG)p9rGF) qLPqFqjVV\U EAJ L]3@x/3Q JSJK++e wcaV(Mc Z+?ua DwDdDO# Yq]%,G]q :S \1A1 Qj;JK[rR u4! Cjo !q}fpn}q )C4J%8 5HEBHwH(rB(3? FmmU1i{MD b% u|n{a N~ikN55Qvk 2B^B%2 ak+ !E? SF7s ]o \@wE\uw7\. fZ )#1KU|2Q Q# Zro ]za8zaazbI _BJ })nu2|JmzX la sPC7PC} Y rjHj%KR \8AX88) y**@I_Ii J\O k|TC!CkY !S gbpgPgprql tAUpJNU1.

sU_g9 :JZ dPr!&Io


Please login or register for full access


Already registered?  Login